Ebr Systems(ASX) EBR

Market CapA$191.55M

Since IPO (2021)-70%

5 YearN/A

1 Year-78%

1 Month-20%

A$0.30

-1.67%

-0.01Today

Ebr Systems last closing stock price
Metric	Price	Date
Last close	AUD 0.30	2026-08-13

Ebr Systems stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+7.14%	AUD 0.28	2026-08-06
1 month	-20%	AUD 0.38	2026-07-14
3 month	-46.9%	AUD 0.57	2026-05-15
Year to date	-66.48%	AUD 0.90	2025-12-31
1 year	-78.42%	AUD 1.39	2025-08-13
3 year	-65.71%	AUD 0.88	2023-08-14
Since inception	-69.7%	AUD 0.96	2021-11-24

Ebr Systems Financials at a Glance

Market Cap

A$191.55M

Revenue (TTM)

$3.97M

Net Income (TTM)

-$55.35M

EPS (TTM)

-A$0.10

P/E Ratio

-3.03

Dividend

A$0.00

Beta (Volatility)

0.20 (Low)

Dividend

A$0.00

Beta (Volatility)

0.20 (Low)

Price

A$0.30

Volume

1,803,270

Open

A$0.31

Price

A$0.30

Volume

1,803,270

Open

A$0.31

Previous Close

A$0.30

Daily Range

A$0.30 - A$0.31

52-Week Range

A$0.24 - A$1.47

Estimated Earnings Date

Aug 3, 2026

Dividend

A$0.00

Beta (Volatility)

0.20 (Low)

Price

A$0.30

Volume

1,803,270

Open

A$0.31

Previous Close

A$0.30

Daily Range

A$0.30 - A$0.31

52-Week Range

A$0.24 - A$1.47

Estimated Earnings Date

Aug 3, 2026

EBR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ebr Systems

EBR Systems, Inc. is a pioneering company in the medical devices sector, specializing in implantable devices that utilize wireless technology for tissue stimulation. The flagship product, the WiSE cardiac resynchronization therapy system, offers a unique solution to traditional pacing challenges by delivering pacing signals directly to the heart's left ventricle.

Products and Services

WiSE cardiac resynchronization therapy system for heart pacing
Innovative wireless technology for tissue stimulation
Focus on overcoming traditional pacing lead challenges

Growth Outlook

Significant market potential in the cardiac device sector
Continued investment in research and development to enhance product offerings
Expansion opportunities in international markets for medical devices

Financial Highlights

Recent quarterly revenue of 2.34 million, showing growth from previous quarters
Trailing twelve months (TTM) revenue of 9.5 million, indicating upward momentum
Current ratio of 4.48, reflecting strong liquidity position

EBR Systems, Inc. has established itself as a leader in innovative cardiac solutions, addressing critical needs in heart pacing technology. The company's focus on research and development positions it well for future growth, particularly in expanding markets. Recent financial performance indicates a positive trajectory, with increasing revenue and a solid liquidity position, making it an intriguing option for potential investors interested in the medical devices sector.

AI Generated • Jul 23, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

135

CEO

John Graham McCutcheon, MBA

Website

www.ebrsystemsinc.com

Headquarters

Sunnyvale, CA 94085, US

EBR Financials

Key Financial Metrics (TTM)

Gross Margin

17.00%

Operating Margin

-1322.69%

Net Income Margin

-1393.29%

Return on Equity

-179.23%

Return on Capital

-56.62%

Return on Assets

-68.58%

Earnings Yield

-33.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$191.55M

Shares Outstanding

638.49M

Volume

1.80M

Avg. Volume

2.98M

Financials (TTM)

Gross Profit

$675.32K

Operating Income

-$52.55M

EBITDA

-$50.39M

Operating Cash Flow

-$60.17M

Capital Expenditure

-$6.93M

Free Cash Flow

-$67.10M

Cash & ST Invst.

$30.03M

Total Debt

$59.85M

Ebr Systems Performance Analysis

Ebr Systems annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A
2025	2025-12-31	USD 2,507,702	N/A

Ebr Systems sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	N/A
Q3	2025-09-30	201.8%
Q4	2025-12-31	85.6%
Q1	2026-03-31	146.2%

Ebr Systems annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.02	-86.0%
2023	2023-12-31	USD -0.02	3.4%
2024	2024-12-31	USD -0.02	3.8%
2025	2025-12-31	USD -0.02	-4.7%

Ebr Systems sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	-0.7%
Q3	2025-09-30	9.3%
Q4	2025-12-31	-15.7%
Q1	2026-03-31	88.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$2.34M

N/A

Gross Profit

$182.32K

N/A

Gross Margin

7.79%

N/A

Market Cap

A$191.55M

N/A

Market Cap/Employee

A$1.42M

N/A

Employees

135

N/A

Net Income

-$16.92M

-60.3%

EBITDA

-$15.90M

-75.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$30.03M

-37.3%

Total Debt

$59.85M

+9.5%

Accounts Receivable

$5.18M

+564.9%

Inventory

$15.57M

+381.8%

Long Term Debt

$58.75M

+8.8%

Short Term Debt

$1.10M

+58.0%

Return on Assets

-68.58%

N/A

Return on Invested Capital

-76.63%

N/A

Free Cash Flow

-$23.33M

-71.2%

Operating Cash Flow

-$20.07M

-47.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PGC.AXParagon Care Limited

PGC.AXParagon Care LimitedA$0.14+3.85%

HLS.AXHealius Limited

HLS.AXHealius LimitedA$0.40-4.29%

IMM.AXImmutep Limited

IMM.AXImmutep LimitedA$0.05-1.92%

RAC.AXRace Oncology Limited

RAC.AXRace Oncology LimitedA$2.01+0.00%

ACL.AXAustralian Clinical Labs Limited

ACL.AXAustralian Clinical Labs LimitedA$2.35-0.64%

CGS.AXCogstate Limited

CGS.AXCogstate LimitedA$2.77+0.91%

CUV.AXClinuvel Pharmaceuticals Limited

CUV.AXClinuvel Pharmaceuticals LimitedA$9.48-1.15%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$8.91-0.09%

SMCISuper Micro Computer

SMCISuper Micro Computer$39.16+0.04%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$141.29-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.64+0.07%

INTCIntel

INTCIntel$104.56+0.04%

NOKNokia

NOKNokia$10.56+0.02%

PATHUiPath

PATHUiPath$16.68+0.09%

Questions About EBR

What is the current price of Ebr Systems?

Ebr Systems is trading at A$0.30 per share.

What is the 52-week range for Ebr Systems?

Over the past 52 weeks, Ebr Systems has traded between A$0.24 and A$1.47.

How much debt does Ebr Systems have?

As of the most recent reporting period, Ebr Systems reported total debt of $86.14M.

How much cash does Ebr Systems have on hand?

Ebr Systems reported $85.67M in cash and cash equivalents in its most recent financial results.

What is Ebr Systems’s dividend yield?

Ebr Systems does not currently have a dividend yield.

Ebr Systems(ASX) EBR

Ebr Systems Financials at a Glance

EBR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Ebr Systems

EBR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Ebr Systems Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About EBR

What is the current price of Ebr Systems?

What is the 52-week range for Ebr Systems?

How much debt does Ebr Systems have?

How much cash does Ebr Systems have on hand?

What is Ebr Systems’s dividend yield?

Premium Investing Services